UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 9, 2013
VISION-SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 000-20970 | | 13-3430173 |
(State or other jurisdiction | | (Registration Number) | | (IRS Employer |
of incorporation) | | Identification No.) | | Identification No.) |
40 Ramland Road South Orangeburg, NY | | 10962 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (845) 365-0600
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
(b) | On September 9, 2013, Vision-Sciences Inc.(the “Company”) issued a press release reportingpositive results from a three-month evaluation completed in 2012 by the British Army at Camp Bastion, a deployed field hospital in Afghanistan.. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. |
ITEM 9.01 | Financial Statements and Exhibits |
(d) | Exhibits |
99.1 | Press release issued by the Company on September 9, 2013. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Vision-Sciences, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VISION-SCIENCES, INC. |
| | |
| | |
| By: | /s/ Howard Zauberman |
| | Name: | Howard Zauberman |
| | Title: | Interim Chief Executive Officer |
Date: September 9, 2013
3
